Despite the higher mortality rates in patients with Down syndrome compared with the general Japanese population, the life span has dramatically increased in Japan and other countries. We aimed to clarify recent causes of death in patients with Down syndrome in Japan. We calculated proportionate mortality and standardized mortality odds ratios (SMORs) among all deaths registered with Down syndrome as the cause of death (ICD-10 code, Q90) in the Japanese National Death Registry Database in 2014–2016. In the study period, 762 in patients with Down syndrome died. The main causes of death were pneumonia/respiratory infections (20.5%), congenital malformations of the circulatory system (11.2%), other diseases of the circulatory system (9.2%), and aspiration pneumonia (8.4%). The SMORs (95% confidence intervals) were higher for natural death, defined as death of an elderly person with no other cause of death to be mentioned (55.73 [36.92–84.12]), early-onset Alzheimer's disease, defined as Alzheimer's disease with onset <65 years of age (29.36 [16.44–52.44]), aspiration pneumonia (18.33 [14.03–23.96]), pneumonia/respiratory infections (8.11 [6.76–9.73]), congenital malformations of the circulatory system (8.07 [5.98–10.88]), and leukemia/lymphoma (2.16 [1.55–2.99]) but lower for malignant solid tumors (0.04 [0.02–0.06]) in patients with Down syndrome. Patients with Down syndrome had the greatest relative risk of dying from natural death, early-onset Alzheimer's disease, and respiratory illnesses, highlighting the need for appropriate medical, health, and welfare services.
11 May 2024 in American Journal of Medical Genetics Part A
It remains unclear whether recent changes in the prognosis and management of patients with trisomy 13 impact patient survival. We investigated changes in survival of patients with trisomy 13 in Japan. Data from the Vital Statistics Database in Japan was retrieved to examine the association of sex, surgical history, and years of birth and death with changes in survival patterns in 1164 patients with trisomy 13 between 1995 and 2021. The rates of deaths due to trisomy 13 increased from 9.8% to 23.1% in those over 1 year of age and from 7.3% to 19.2% in those within 24 h of birth between 1995 and 2021. The median survival time was longer in 2009–2021 than in 1996–2008 (40 vs. 84 days, p < 0.001). The median survival time and the rate of patients with surgical history increased from 91 days and 16.0% in 1996–2008 to 179 days and 28.0% in 2009–2021, respectively. Median survival time among patients with trisomy 13 has increased over the last 26 years, with almost 1 in 3 patients currently surviving for more than 1 year. The increased surgical intervention rate might have contributed to this improvement.
19 September 2025 in American Journal of Medical Genetics Part A
Trisomy 13, the third most common autosomal trisomy after trisomy 21 and trisomy 18, is associated with a significantly high infant mortality rate. However, large‐scale studies examining causes of death in trisomy 13 remain scarce. Therefore, we aimed to better understand the mortality patterns. To this end, a population‐based study was conducted using Japanese population‐based mortality data from the Vital Statistics Database ( n = 4,230,092 death records); we examined early mortality and identified phenotypic subgroups based on combinations of co‐occurring causes of death. We identified 150 individuals with trisomy 13 who died between 2019 and 2021. Cardiovascular disease was significantly associated with early mortality. Using K ‐means clustering based on principal components of cause‐of‐death categories, we identified three distinct subgroups: respiratory‐dominant (19%), cardiovascular‐dominant (64%), and multi‐organ involvement (17%). The cardiovascular‐dominant cluster showed the highest rate of death before age 1 (83%; p = 0.001), while surgical intervention rates did not significantly differ across clusters. These findings highlight phenotypic heterogeneity and may support individualized care planning for trisomy 13 and provide insights that may support future care and decision‐making.
Objectives: To examine age-specific growth patterns derived from Japanese cross-sectional data according to infants’ feeding and determine whether differences persist through preschool age. Methods: We analyzed secondary data from the 2023 National Growth Survey on Preschool Children in Japan, a single-wave nationwide cross-sectional survey. The participants were 8028 singleton, term-born, appropriate-for-gestational-age children aged 0–60 months without major health conditions. The feeding history up to 24 months was reported by parents and categorized as breastfed, formula-fed, or mixed-fed. Anthropometric measurements were obtained at a 1-month postnatal checkup or at checkups arranged for the survey, converted to standard deviation scores using Japanese references, and modeled with growth curves using the Lambda–Mu–Sigma method to summarize cross-sectional distributions by age. The feeding groups were compared at selected ages. Results: Breastfed infants were smaller in length/height and weight than formula-fed peers during the first 2 years, with the largest differences in infancy. The mean stature in the feeding groups became similar at older ages; by 60 months, standard deviation scores for stature and weight were comparable across the feeding groups. Head circumference patterns up to 36 months were not different by the feeding category. Conclusions: In Japan, early size differences by the feeding group show age-related convergence of cross-sectional group means by preschool, and head circumference patterns are similar across the groups. These findings support breastfeeding as sufficient for long-term growth without unnecessary formula supplementation.